Form and dose:
Modified release tablets, 680 mg
Calcium nephrolithiasis in patients with low urinary citrate excretion. Renal distal tubular acidosis, metabolic acidosis in chronic renal failure with no significant reduction in daily urine volume and without hyperkalemia. Supplementing potassium deficiency in the body. Other pathological conditions requiring chronic urine alkalinization.
Marketing authorization number:
+ 48 71 325 30 85/86